INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

This adverse event was reported 86675 times

These drugs are most commonly taken by patients reporting INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION:

# Drug Count
0 ADAPALENE 15169
1 AVOBENZONE, OCTISALATE, AND OCTOCRYLENE 12468
2 INSULIN GLARGINE 6051
3 SALICYLIC ACID 4610
4 PREDNISONE 4219
5 INFLIXIMAB 4066
6 ACETAMINOPHEN 3779
7 SECUKINUMAB 3560
8 INFLIXIMAB-DYYB 3243
9 METHOTREXATE SODIUM 3108
See all common drugs associated with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 INFLIXIMAB-DYYB 3243 0.2394
1 BENZOYL PEROXIDE 598 0.1032
2 AZATHIOPRINE SODIUM 108 0.0994
3 COAL TAR 52 0.0963
4 AVOBENZONE, OCTISALATE, AND OCTOCRYLENE 12468 0.0960
5 ROPEGINTERFERON ALFA-2B 23 0.0943
6 SALICYLIC ACID 4610 0.0927
7 ADAPALENE 15169 0.0912
8 AVATROMBOPAG MALEATE 70 0.0797
9 RITUXIMAB-PVVR 74 0.0791
See all drugs enriched for association with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION

INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interferon alfa-2b [EPC] 23 0.0943
1 Retinoid [EPC] 15438 0.0703
2 Human Immunoglobulin G [EPC] 393 0.0658
3 Interleukin-17 Receptor A Antagonist [EPC] 63 0.0640
4 Parathyroid Hormone [EPC] 191 0.0445
5 Chemokine Receptor Type 4 Interaction [EPC] 30 0.0369
6 Methylating Agent [EPC] 27 0.0366
7 GLP-2 Analog [EPC] 270 0.0328
8 Melanocortin 4 Receptor Agonist [EPC] 1 0.0323
9 Opioid Antagonist [EPC] 19 0.0302
See all drug classes enriched for association with INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION